Last reviewed · How we verify

NCT03444688

Development and Evaluation of a Novel Portable Robotic Gait Rehabilitation in Chronic Stroke

Status unknown NA Last updated 10 April 2018
What this trial tests

NA trial testing Conventional Gait Training in Stroke in 100 participants. Status unknown.

Timeline
2 April 2018
Primary endpoint
10 December 2018
10 December 2018

Quick facts

Lead sponsorNational University Hospital, Singapore
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date2 April 2018
Primary completion10 December 2018
Estimated completion10 December 2018
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

National University Hospital, Singapore

Who can join

Adults 50 to 90, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this study is to test the training effects of the robotic walker. This study will compare the effectiveness of 2 different types of gait training protocols in chronic stroke patients, 1) conventional gait training (CT, control group), and 2) gait rehabilitation with the new walker modified after 1st stage (WT, experimental group).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Electromechanical-assisted training for walking after stroke.
    Mehrholz J, Thomas S, Kugler J, Pohl M, et al · · 2020 · cited 146× · PMID 33091160 · DOI 10.1002/14651858.cd006185.pub5

Verify or expand the search:

Other trials of Conventional Gait Training

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other National University Hospital, Singapore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03444688.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing